drugset / Trial / NCT07172646
A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a two-part study, intended to investigate the safety, tolerability, characteristics of PK and PD of single SC dose of SRSD216 and to identify a dose range for further studies in subjects with elevated Lp(a) level with or without ASCVD history.
Timeline
- Start
- 2025-04-07
- Primary completion
- 2026-05
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SRSD216 | Unknown | — | Subcutaneous |